PubMed Health⌕ Search

Biomedical subjects

W A Cafruny

Publications and source records attributed to W A Cafruny.

28 records · Page 2Linked to original sources
PubMed1986

Immunoglobulins that bind to uncoated ELISA plate surfaces: appearance in mice during infection with lactate-dehydrogenase-elevating virus and in human anti-nuclear antibody-positive sera.

Immunoglobulins present in the blood plasma of mice infected with lactate-dehydrogenase-elevating virus (LDV) were found to bind strongly in the presence of 0.05% Tween 20 to the uncoated surfaces of wells of certain ELISA plates with previously recognized high protein-binding capacity. The binding was readily distinguishable from non-specific background binding of immunoglobulins present in normal mouse plasma. The binding components absorbed to protein A and had molecular weights in the 150-300 kDa range. Binding of the purified IgG fraction was progressively inhibited by increasing the concentration of Tween 20 in the diluent and by preincubation of the fraction at pH 3-4 for 10 min. The appearance of plate-binding IgM and IgG during LDV infection corresponded approximately with previously reported time courses of appearance of IgM- and IgG-containing circulating immune complexes and of specific IgM and IgG anti-LDV antibodies in LDV-infected mice. We conclude that complexes of IgG and IgM with LDV antigens have a much higher affinity for ELISA plates with high protein-binding capacity than uncomplexed immunoglobulins. Immune complexes did not significantly bind to ELISA plates with low protein-binding capacity, which, therefore, are suitable for measuring specific antiviral antibodies. Preliminary experiments with human anti-nuclear antibody-positive serum samples demonstrated markedly elevated non-specific binding of immunoglobulins to high-binding-capacity ELISA plates.

Animals↗
PubMed1986

Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus.

BALB/c and Swiss mice were infected with lactate dehydrogenase-elevating virus (LDV) or immunized with glutaraldehyde-inactivated or ether-extracted virus and their plasma was monitored for anti-LDV IgG and IgM levels by ELISA and indirect fluorescent antibody staining, for neutralizing antibodies, for sensitized antibody-virus complexes, for immune complexes, and for total plasma IgG and IgM. In infected mice, anti-LDV IgM was transiently formed during the first 2 weeks post infection (p.i.) but only at a low level. Anti-LDV IgG was produced in a biphasic manner with an initial peak at about 10 days p.i. and a secondary rise reaching a maximum level 30-80 days p.i. which was retained throughout the persistent phase of infection. The concomitant appearance of comparable levels of low molecular weight immune complexes suggests that most anti-LDV IgG was complexed with LDV proteins. Also, as early as 10 days p.i., infectious antibody-LDV complexes developed, which were neutralizable by rabbit anti-mouse IgG, whereas antibodies that neutralize the infectivity of exogenously added LDV appeared only 1-2 months p.i. Throughout infection, most of the anti-LDV IgG was directed to VP-3, the envelope glycoprotein of LDV, which was found to exist in at least 10 distinct forms ranging in molecular weight from 24 to 42 kDa. Anti-LDV IgG levels as high as those observed in infected mice developed in mice immunized with inactivated LDV. Antibodies to glutaraldehyde-inactivated LDV were also mainly directed to VP-3, but exhibited no neutralizing activity. The polyclonal B cell activation associated with a persistent LDV infection and the formation of immune complexes were not observed in mice immunized with inactivated virus.

Animals↗
PubMed1986

Replication of lactate dehydrogenase-elevating virus in C58 mice and quantification of antiviral antibodies and of tissue virus levels as a function of development of paralytic disease.

Infection with the lactate dehydrogenase-elevating virus (LDV) triggers a generally fatal paralytic disease in old immunosuppressed C58 mice, but not in comparable mice of many other strains. We have compared the replication of LDV and the humoral immune response to it in C58 mice and mice of various resistant strains. Plasma LDV titres of persistently infected C58 mice were about tenfold higher than in other strains of mice and the proportion of LDV-permissive macrophages in peritoneal exudates of C58 mice was about twice as high as that observed in other mouse strains. C58 mice developed normal levels of anti-LDV IgG, as measured by ELISA, and normal levels of IgG that sensitized LDV to neutralization by rabbit anti-mouse IgG. C58 mice also developed normal IgM and IgG responses to human gamma-globulin and sheep erythrocytes. The antibody responses to LDV were similarly inhibited by cyclophosphamide in C58 and resistant strains of mice, which enhanced the incidence of signs of paralysis only in C58 mice. Thus, the sensitivity of C58 mice to LDV-induced paralytic disease is not due to an inherent inability of the mice to mount a humoral antibody response to LDV, and a suppression of the antibody response by cyclophosphamide is not the only prerequisite for development of the disease. We have quantified LDV in various tissues of immunosuppressed and non-immunosuppressed, 8- or 9-month-old C58 mice as a function of time after LDV infection and in relation to the development of paralytic disease. Changes in tissue LDV titres as a function of time after infection paralleled those found in the plasma; LDV titres were highest 1 day post-infection, and then decreased to a lower persistent level during the next 1 to 2 weeks. Tissue LDV titres, including those of the spinal cord, were lower than those in the plasma, and our results indicate that most of the LDV in tissue homogenates may be attributable to blood contamination, even though the animals were extensively perfused before removal of the tissues.

Aging↗
PubMed1984

Protein A-binding immunosuppressive mouse serum factors.

In this study protein A of Staphylococcus aureus has been used to isolate an immunosuppressive component present in mouse serum. The suppressive effect of mouse serum on lymphocyte activation was partially abrogated by prior adsorption on protein A, and also by ammonium sulfate precipitation or specific immune precipitation with anti-IgG but not with anti-IgM. Protein A-binding material was isolated after chromatography on protein A-Sepharose and studied in spleen cell cultures. Protein A eluates from normal or NZB/NZW mice were found to suppress concanavalin A (Con A)-activated normal mouse spleen cells, and suppression was more potent with NZB/NZW serum isolates. Suppressive activity was dependent upon the dose of eluate added to cell cultures. The suppressive effect of NZB/NZW protein A-binding material was apparent in both Con A- and lipopolysaccharide (LPS)-stimulated normal mouse spleen cells, and required early addition to the cell cultures or preincubation with target lymphocytes. The suppressive activity was not detectably cytotoxic during a suppressive preincubation period. The possible relevance of these observations to experimental strategies in tumor immunotherapy is discussed.

Animals↗
PubMed1982

Replication of lactate dehydrogenase-elevating virus in macrophages. 1. Evidence for cytocidal replication.

Cultures of starch-elicited peritoneal mouse macrophages in medium containing macrophage growth factor (MGF) were infected with lactate dehydrogenase-elevating virus (LDV) and, after various times in culture, LDV production was monitored as a function of time by infectivity titrations in mice, by measuring [3H]uridine incorporation into LDV RNA and extracellular LDV, by autoradiographic analysis of the proportion of productively infected cells and by electron microscopy. Regardless of the age of the cultures when infected with LDV, only a small proportion of the macrophages (generally between 3 and 20% of the total) became productively infected after a primary infection; maximum virus RNA synthesis and virus production occurred during the first 24 h after infection and then decreased precipitously. Productively infected macrophages could be readily recognized in electron micrographs of 24-h infected macrophage cultures and in sections of spleens from 24-h infected mice by characteristic morphological alterations. These consisted of formation of clusters of double-membrane vesicles with a diameter of 100 to 300 mumol, budding of nucleocapsids into vesicles with single membranes and accumulation of mature virions in these vesicles. One to 4 days later, however, such cells were no longer found in infected cultures or spleens of infected mice and superinfection did not restimulate LDV replication. Cultures established with macrophages from 1-day LDV-infected mice also did not support LDV replication. We conclude that LDV replication in cultures or mice is limited to a single cycle in a subpopulation of macrophages and that infection leads to cell death and rapid phagocytosis of the dead cells by the resistant, uninfected macrophages.

Animals↗
PubMed1982

Acute infection of mice with lactate dehydrogenase-elevating virus enhances Fc and complement receptor activity of peritoneal macrophages.

Peritoneal macrophages isolated from Balb/c mice 1 day after infection with lactate dehydrogenase-elevating virus (LDV) exhibited a 5- to 10-fold enhancement of attachment and ingestion of sheep red blood cells coated with immunoglobulin (EAIgG) or immunoglobulin plus complement (EAIgMC). Macrophages isolated from mice 7 days after LDV infection or macrophages infected with LDV in culture were also slightly more active than macrophages from uninfected mice, but the differences were not significant. The results indicate that a specific increase in the number of Fc and C3 receptors on macrophages occurs during the acute phase of infection. This increase correlates with the transient appearance of interferon in acutely infected mice. We postulate that during the acute phase the productive infection of a subpopulation of macrophages that is permissive for LDV results in the synthesis of sufficient interferon to cause activation of the remaining non-permissive macrophages in the animal.

Animals↗
PubMed1982

Immune response to lactate dehydrogenase-elevating virus: isolation of infectious virus-immunoglobulin G complexes and quantitation of specific antiviral immunoglobulin G response in wild-type and nude mice.

Lactate dehydrogenase-elevating virus (LDV) causes a normally benign persistent infection of mice, resulting in a life-long viremia characterized by the presence of circulating infectious immune complexes, impaired clearance of certain enzymes from the blood, and modification of the host immune response to various heterologous antigens. In this study, we isolated infectious immunoglobulin G (IgG)-LDV complexes in the plasma of persistently infected mice by adsorption to and elution from protein A-Sepharose CL-4B. We found that practically all infectious LDV in the plasma of persistently infected mice is complexed to IgG. LDV infectivity in these complexes was partially neutralized, but could be reactivated by treatment with 2-mercaptoethanol. We also quantitated total plasma IgG and anti-LDV IgG in wild-type and nude Swiss and BALB/c mice as a function of the time after infection with LDV by radial immunodiffusion and an enzyme-linked immunosorbent assay, respectively. Total plasma IgG levels nearly doubled in BALB/c mice during 150 days of infection. IgG levels in uninfected nude mice were only 20% of those in uninfected BALB/c mice, but during infection with LDV increased to approximately those found in uninfected BALB/c mice. Anti-LDV IgG levels were almost as high in nude mice as in normal BALB/c mice. Isoelectric focusing of purified IgG from BALB/c mice showed that LDV infection resulted in the enhanced synthesis of all 16 normal IgG fractions that we could separate by this method, which suggests that LDV infection results in polyclonal activation of IgG-producing lymphocytes.

Animals↗
PubMed1982

Immune response to lactate dehydrogenase-elevating virus: serologically specific rabbit neutralizing antibody to the virus.

A rabbit was immunized with large amounts of the lactate dehydrogenase-elevating virus (LDV) over a 9-month period. The plasma from this rabbit possessed an anti-LDV IgG titer of 1:80,000 as measured by the enzyme-linked immunosorbent assay (ELISA) method and a neutralizing titer of 1:1,000 for the homologous strain of LDV. LDV neutralization at 4 degrees C followed single-hit kinetics. In contrast, mouse anti-LDV IgG in plasma of chronically LDV-infected mice failed to neutralize LDV at 4 degrees C and neutralization at 37 degrees C was slow, biphasic, and inefficient compared with the neutralization caused by rabbit anti-LDV IgG, even though high levels of anti-LDV IgG were detectable in mouse plasma by the ELISA method. Rabbit anti-LDV IgG neutralized one heterologous strain of LDV as rapidly as it did the homologous strain, but failed to significantly neutralize five other strains of LDV, all of which were originally isolated from different mouse strains bearing transplantable tumors. The results indicate clear serological differences between LDV strains. Cross-reactions between the strains, however, were observed by ELISA, using the antibody induced during persistent infection of mice with each LDV strain. Immunoglobulin M (IgM) from mice infected for 15 days with the various strains bound equally to our LDV strain. IgG obtained from 2-month-infected mice also cross-reacted, but to a varying extent which partly correlated with the specificity detected by neutralization. Both rabbit and mouse anti-LDV IgG enhanced the infectivity of LDV at a low multiplicity of infection for primary cultures of peritoneal mouse macrophages.

Animals↗
PubMedDate not supplied

Immunoglobulin transfer from immune-reconstituted SCID mice to nursing neonates: blood distribution of antibody and association with perinatal virus protection.

Previous work in our laboratory has shown that fetal protection from maternal transmission of the murine lactate dehydrogenase-elevating virus (LDV) infection is mediated by adoptive transfer of maternal anti-viral immunity. In the present report, we have characterized reconstitution of immunity in immunodeficient SCID mice following transplantation with BALB/c spleen cells, and studied the fate and distribution of maternally-derived antibodies after passage to neonatal SCID mice by nursing. Immune-reconstituted SCID mice maintained stable immunity for up to 7 months post-transplantation, during which time they produced nonneutralizing IgG anti-LDV antibodies and protected their offspring from maternally-derived LDV infection. Using IgG isotype and allotype assays, it was found that maternal IgG antibodies transferred from breast milk to nursing neonatal mice and appeared in their circulation. Weaning of SCID mice from immunocompetent mothers permitted the determination of blood immunoglobulin isotype half-lives (3.6-10.6 days) in the absence of endogenous antibody production. LDV infection was transferred to nursing mice by nonimmune LDV-infected mothers, but protection from nursing-acquired LDV infection was associated with maternal viral immunity, breast milk transfer of IgG anti-LDV to nursing mice, and reduced breast milk virus titers. These findings show a nursing pathway for LDV infection, and demonstrate the potential of immune protection from this infection pathway.

Animals↗